英文名称:ZYFLO CR®(zileuton)
中文名称:齐留通12小时缓释片
品牌生产商:CORNERSTONE THERAPEUTICS INC.
药品介绍
英国SkyePharma公司已与美国私营公司CriticalTherapeutics达成协议,开发口服齐留通(zileuton)(Ⅰ)的控释(CR)配方,用于治疗哮喘和慢性阻塞性肺病(COPD)。 齐留通每日四次的速释配方已由AbbottLaboratories公司以商品名ZyfloFilmtab上市。SkyePharma公司已采用Geomatrix技术开发了该化合物的CR配方,Abbott公司已完成了Ⅲ期试验。 SkyePharma公司将与CriticalTherapeutics公司协作进一步开发(Ⅰ)的控释配方用于中至重度哮喘和COPD。
ZYFLO CR(齐留通)缓释片 初始美国批准:1996
适应症 ZYFLO CR是一种白三烯合成抑制剂对预防和成人和儿童12岁以上的哮喘治疗慢性表示。
不要使用ZYFLO CR治疗急性哮喘发作 剂量和用法 成人和儿童12岁以上:对ZYFLO CR推荐剂量为两台600毫克缓释片,每天两次一小时内,经过上午和晚上吃饭,共计每日2400毫克的剂量。
监测:评估肝功能酶之前,ZYFLO CR启动和治疗期间定期监测。 剂型和规格 缓释片:600毫克 禁忌 活动性肝病或持续肝功能酶升高≥3倍正常上限 史或过敏性反应,齐留通的ZYFLO CR的任何一种成分。 警告和注意事项 肝毒性:一个或多个肝功能酶和胆红素升高可能会出现ZYFLO CR。评估肝功能酶之前,ZYFLO CR,为前3个月每月,为今年余下的每首2-3个月开始,并在此后定期。使用与患者谁消耗的酒精和/大批量或有肝病史慎用ZYFLO CR。
神经精神活动:神经精神事件,包括睡眠障碍和行为的改变,可能会出现ZYFLO CR。指导患者为神经精神事件的警报。评估与ZYFLO CR持续治疗的风险和收益,如果这样的事件发生。 不良反应 最常见(≥5%)的不良反应包括:鼻窦炎,恶心,咽喉疼痛。 药物相互作用 齐留通增加茶碱水平。降低茶碱剂量和监测水平。 齐留通加华法令水平。监测凝血酶原时间及相应的调整华法林剂量。 齐留通加普萘洛尔水平和β-阻断剂的活性。监视器适当。
特殊族群使用 肝功能不全:ZYFLO CR是在活动性肝病和肝功能酶升高≥3倍正常上限的患者禁忌。 修订:10/2009 附件:该药品相关信息网址1: http://www.drugs.com/cons/zyflo.html 该药品相关信息网址2: http://www.rxlist.com/zyflo-drug.htm
【用 途】用于风湿性关节炎、过敏性鼻炎、哮喘病和溃疡性结肠炎。 Zyflo和Zyflo CR (齐留通)是一种白三烯合成抑制剂。白三烯合成抑制剂通过终止某些可引起气道内水肿、收缩和黏液产生的物质形成而起效。Zyflo和Zyflo CR也是用于治疗哮喘。
【原产地英文商品名】ZYFLO CR 12HR 600mg/tab 120tabs/bottle 【原产地英文药品名】ZILEUTON 【原产地英文化合物名称】Urea, N-(1-Benzo[b]thien-2-ylethyl)-N-hydroxy- 中文参考商品译名】ZYFLO 12小时缓释片 600毫克/片 120片/瓶 【中文参考药品译名】齐留通 【生产厂家中文参考译名】CORNERSTONE THERAPEUTICS INC. 【生产厂家英文名】CORNERSTONE THERAPEUTICS INC.
ZyfloZYFLO CR®(zileuton) Extended-Release Tablets
Partner: Cornerstone Therapeutics, Inc. SkyePharma developed a controlled-release formulation of zileuton for Cornerstone Therapeutics. ZYFLO CR® is a leukotriene synthesis inhibitor oral anti-inflammatory asthma drug, utilizing SkyePharma’s Geomatrix™ technology that allows the dosing to be reduced from four times a day to twice a day. ZYFLO CR® received FDA approval in 2007 and was launched in the US in September 2007 for the prevention and chronic treatment of asthma in adults and children 12 years of age and older. ZYFLO CR® is not indicated for use in the reversal of bronchospasm in acute asthma attacks. Therapy with ZYFLO CR® and ZYFLO® can be continued during acute exacerbations of asthma. Generic Name: zileuton (Oral route) zye-LOO-tonCommonly used brand name(s):In the U.S. Zyflo Zyflo CR
Available Dosage Forms: Tablet Tablet, Extended Release
Therapeutic Class: Anti-Inflammatory
Pharmacologic Class: Leukotriene Pathway Inhibitor
-------------------------------------------------------
Uses For Zyflo Zileuton is used by patients with mild-to-moderate chronic asthma to decrease the symptoms of asthma and the number of acute asthma attacks. However, this medicine should not be taken to relieve an asthma attack that has already started.
This medicine is available only with your doctor's prescription.
Zileuton immediate-release tablets (Zyflo(R)) were withdrawn from the U. S. market by Critical Therapeutics on February 12, 2008. The extended-release formulation of zileuton (Zyflo CR(R)), also manufactured by Critical Therapeutics, Inc, is still available.
Before Using Zyflo In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:
Allergies Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.
Pediatric Appropriate studies have not been performed on the relationship of age to the effects of zileuton in children younger than 12 years of age. Safety and efficacy have not been established.
Geriatric Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of zileuton in the elderly. However, elderly patients are more likely to have age-related liver disease, and this medicine should not be used in patients with this condition.
Pregnancy All Trimesters Pregnancy Category:C Explanation:Animal studies have shown an adverse effect and there are no adequate studies in pregnant women OR no animal studies have been conducted and there are no adequate studies in pregnant women.
Breast Feeding There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.
Interactions with Medicines Using this medicine with any of the following medicines is not recommended. Your doctor may decide not to treat you with this medication or change some of the other medicines you take.
Dihydroergotamine Ergoloid Mesylates Ergonovine Ergotamine Methylergonovine
Using this medicine with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.
Astemizole Eltrombopag Pimozide Terfenadine Theophylline Tizanidine
Using this medicine with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be the best treatment for you. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.
Propranolol Warfarin
Interactions with Food/Tobacco/Alcohol Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.
Other Medical Problems The presence of other medical problems may affect the use of this medicine. Make sure you tell your doctor if you have any other medical problems, especially: Alcohol use, severe or Liver disease, history of—Use with caution. The chance of serious side effects may be increased. Liver disease, active—This medicine should not be used with this condition.
-------------------------------------------------------
Proper Use of zileuton This section provides information on the proper use of a number of products that contain zileuton. It may not be specific to Zyflo. Please read with care.
Zileuton is used to prevent asthma attacks. It is not used to relieve an attack that has already started. For relief of an asthma attack that has already started, you should use another inhaled medicine that works quickly. If you have any questions about this, check with your doctor.
Swallow the extended-release tablet whole. Do not crush, break, or chew it.
To work properly, zileuton must be taken every day at regularly spaced times, even if your asthma seems better.
Dosing The dose of this medicine will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of this medicine. If your dose is different, do not change it unless your doctor tells you to do so.
The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.
For oral dosage form (extended-release tablets): For asthma prevention: Adults and children 12 years of age and older—Two 600 milligram (mg) tablets two times a day, within one hour after morning and evening meals. Children up to 12 years of age—Use and dose must be determined by your doctor. Missed Dose If you miss a dose of this medicine, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses.
Storage Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light. Keep from freezing.
Keep out of the reach of children.
Do not keep outdated medicine or medicine no longer needed.
Ask your healthcare professional how you should dispose of any medicine you do not use.
-------------------------------------------------------
Precautions While Using Zyflo It is very important that your doctor check your progress at regular visits. This will allow your doctor to see if the medicine is working properly and to check for unwanted effects.
Check with your doctor if you are using more inhalations (puffs) than usual of your inhaled bronchodilator to relieve an acute asthma attack.
You may be taking other medicines for asthma along with zileuton. Do not stop taking or reduce the dose of the other medicines, even if your asthma seems better, unless you are told to do so by your doctor.
You should limit the amount of alcohol you drink while you are taking this medicine.
This medicine may cause some people to be agitated, irritable, or display other abnormal behaviors. It may also cause some people to have suicidal thoughts and tendencies or to become more depressed and have problems with sleep. If you or your caregiver notice any of these side effects, tell your doctor right away.
-------------------------------------------------------
Zyflo Side Effects Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur:
Rare Flu-like symptoms itching right upper stomach pain unusual tiredness or weakness yellow eyes or skin
Incidence not known Attack, assault, or force attempts at killing oneself discouragement dry mouth fear or nervousness feeling sad or empty hyperventilation irregular heartbeats irritability lack of appetite loss of interest or pleasure restlessness seeing, hearing, or feeling things that are not there shakiness in the legs, arms, hands, or feet shortness of breath sleeplessness tiredness trembling or shaking of the hands or feet trouble with concentrating trouble with sleeping unable to sleep
Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
More common Cough fever headache nausea pain or tenderness around the eyes and cheekbones stuffy or runny nose tightness of the chest or wheezing troubled breathing upset stomach
Less common Abdominal or stomach pain sore throat weakness
Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.
Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.
The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.
The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products. |